IVUS leads to a higher rate of revascularisation in intermediate coronary lesions but does not influence clinical outcomes compared to FFR assessment.
Does IVUS compared to FFR affect clinical outcomes and revascularization rates in patients with intermediate coronary lesions?
Both IVUS and FFR are safe for deferring revascularization in intermediate coronary lesions, though IVUS leads to a higher rate of revascularization without altering overall clinical outcomes.
Tasa de eventos absoluta: 0% vs 0%
IVUS and FFR may be safely used to defer revascularisation of intermediate lesions. IVUS induces a higher degree of revascularisation but much lower than previously reported and does not affect the clinical outcome.
Hernández et al. (Fri,) reported a other. IVUS leads to a higher rate of revascularisation in intermediate coronary lesions but does not influence clinical outcomes compared to FFR assessment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: